These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16001797)

  • 21. Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics.
    Fass R
    J Clin Gastroenterol; 2007 Feb; 41(2):131-7. PubMed ID: 17245209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study.
    Nocon M; Labenz J; Jaspersen D; Meyer-Sabellek W; Stolte M; Lind T; Malfertheiner P; Willich SN
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1728-31. PubMed ID: 17914941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nighttime heartburn in patients with gastroesophageal reflux disease under routine care.
    Nocon M; Labenz J; Jaspersen D; Leodolter A; Meyer-Sabellek W; Stolte M; Vieth M; Lind T; Malfertheiner P; Willich SN
    Digestion; 2008; 77(2):69-72. PubMed ID: 18349541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiology, diagnosis and treatment of non-erosive reflux disease (NERD).
    Papa A; Urgesi R; Grillo A; Danese S; Guglielmo S; Roberto I; Fedeli G; Gasbarrini A; Gasbarrini G
    Minerva Gastroenterol Dietol; 2004 Sep; 50(3):215-26. PubMed ID: 15729197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Non-erosive gastroesophageal reflux disease. Incidence of clinical forms, characteristics of esophageal exposure to acid and symptomatic correlations].
    Soto Pérez JC; Icaza ME; Vargas F; Valdovinos Díaz MA
    Rev Gastroenterol Mex; 2003; 68(2):113-9. PubMed ID: 15127647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies.
    Laine L; Sugg J
    Am J Gastroenterol; 2002 Dec; 97(12):2992-7. PubMed ID: 12492181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relevance of ineffective esophageal motility and hyperactive acid sensitization in patients with gastroesophageal reflux.
    Hong SJ; Ko BM; Jung IS; Ryu CB; Moon JH; Cho JY; Kim JO; Lee JS; Lee MS; Shim CS; Kim BS
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1662-5. PubMed ID: 17559356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treat or investigate?
    Galmiche JP
    Eur J Gastroenterol Hepatol; 1999 Jun; 11 Suppl 1():S11-5. PubMed ID: 10443907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On-demand therapy is a valid strategy in GERD patients: pros and cons.
    Leodolter A; Penagini R
    Dig Dis; 2007; 25(3):175-8. PubMed ID: 17827935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid.
    Shapiro M; Green C; Bautista JM; Peru RL; Malagon IB; Corvo M; Risner-Adler S; Beeler JN; Tuchinsky I; Fass R
    Am J Gastroenterol; 2006 May; 101(5):1084-91. PubMed ID: 16573776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
    Watson TJ; Peters JH
    Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of non-erosive reflux disease.
    El-Serag HB
    Digestion; 2008; 78 Suppl 1():6-10. PubMed ID: 18832834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart rate variability in patients with different manifestations of gastroesophageal reflux disease.
    Lee YC; Wang HP; Lin LY; Lee BC; Chiu HM; Wu MS; Chen MF; Lin JT
    Auton Neurosci; 2004 Nov; 116(1-2):39-45. PubMed ID: 15556836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment.
    Calabrese C; Bortolotti M; Fabbri A; Areni A; Cenacchi G; Scialpi C; Miglioli M; Di Febo G
    Am J Gastroenterol; 2005 Mar; 100(3):537-42. PubMed ID: 15743348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiology and management of gastroesophageal reflux disease.
    Rohof WO; Hirsch DP; Boeckxstaens GE
    Minerva Gastroenterol Dietol; 2009 Sep; 55(3):289-300. PubMed ID: 19829285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of measurement of esophageal acid exposure close to the gastroesophageal junction on diagnostic accuracy and event-symptom correlation: a prospective study using wireless dual pH monitoring.
    Bansal A; Wani S; Rastogi A; Rastogi K; Goyal A; Hall S; Singh V; Higbee A; Sharma P
    Am J Gastroenterol; 2009 Dec; 104(12):2918-25. PubMed ID: 19755975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Power spectral analysis of the sleep electroencephalogram in heartburn patients with or without gastroesophageal reflux disease: a feasibility study.
    Budhiraja R; Quan SF; Punjabi NM; Drake CL; Dickman R; Fass R
    J Clin Gastroenterol; 2010 Feb; 44(2):91-6. PubMed ID: 19661813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnostic usefulness of the Carlsson-Dent questionnaire in gastroesophageal reflux disease (GERD)].
    Gómez-Escudero O; Remes-Troche JM; Ruíz JC; Peláez-Luna M; Schmulson MJ; Valdovinos Díaz MA
    Rev Gastroenterol Mex; 2004; 69(1):16-23. PubMed ID: 15193059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease.
    Lee ES; Kim N; Lee SH; Park YS; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
    Aliment Pharmacol Ther; 2009 Jul; 30(2):154-64. PubMed ID: 19392871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oesophageal hypersensitivity in Japanese patients with non-erosive gastro-oesophageal reflux diseases.
    Miwa H; Minoo T; Hojo M; Yaginuma R; Nagahara A; Kawabe M; Ohkawa A; Asaoka D; Kurosawa A; Ohkusa T; Sato N
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():112-7. PubMed ID: 15298616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.